Trametinib gsk 1120212
Trametinib (GSK-1120212) is a small-molecule inhibitor that targets the mitogen-activated protein kinase (MAPK) pathway by inhibiting MEK1 and MEK2. It is a white to off-white powder that is soluble in DMSO and dimethyl formamide.
Lab products found in correlation
3 protocols using trametinib gsk 1120212
Reconstitution and Preparation of Immunotherapeutic Agents
Exploring Anticancer Drug Compounds
Compound Screening Assay Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!